Stocks Health care XTXXF

OTC · Health care

Adastra Holdings Ltd. (XTXXF)

Adastra Holdings Ltd. reported revenue of CA$13.3M in fiscal 2022, up 136.2% from a year earlier. It posted a net loss of CA$4.3M. Operating cash flow minus capital spending left CA$694.1K of free cash flow in fiscal 2022. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 17, 2023.

Watch XTXXF in 60 seconds

Follow XTXXF

Free, no password. An email when XTXXF files with the SEC.

Key facts about Adastra Holdings Ltd.

Net worth

Adastra Holdings Ltd. reported shareholders' equity (book value: assets minus liabilities) of CA$18.2M at December 31, 2022. We hold no current market value for it.

Revenue and profit

In fiscal 2022 revenue was CA$13.3M (+136.2% year on year), with a net loss of CA$4.3M.

Cash flow

In fiscal 2022 operations brought in CA$1.3M of cash; after CA$625K of capital spending, free cash flow was CA$694.1K.

Latest report

The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on May 17, 2023 and covers the period to December 31, 2022. Open on SEC EDGAR

What Adastra Holdings Ltd. does

Adastra Holdings Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker XTXXF.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in CAD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Adastra Holdings Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. May 1, 2024
   Deregistration 15-12G
2. December 6, 2023
   Foreign issuer update 6-K
3. August 18, 2023
   Foreign issuer update 6-K
4. May 31, 2023
   Foreign issuer update 6-K
5. May 17, 2023
   Annual report (foreign issuer) 20-F · period to December 31, 2022Revenue rose 136% to 13.3M CAD versus the prior year; diluted EPS -0.07 CAD versus -0.05 CAD.
6. May 4, 2023
   Foreign issuer update 6-K
7. May 4, 2023
   Foreign issuer update 6-K
8. April 26, 2023
   Form NT 20-F filing NT 20-F
9. April 14, 2023
   Foreign issuer update 6-K
10. March 20, 2023
    Foreign issuer update 6-K

Insider trades

What the people running Adastra Holdings Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about XTXXF

What does Adastra Holdings Ltd. do?

Adastra Holdings Ltd. is a company in the Health care sector, listed on OTC as XTXXF. Its shares trade on OTC under the ticker XTXXF.

What is Adastra Holdings Ltd.'s net worth?

Adastra Holdings Ltd. reported shareholders' equity (book value: assets minus liabilities) of CA$18.2M at December 31, 2022. We hold no current market value for it.

Is Adastra Holdings Ltd. profitable?

No. In fiscal 2022 it reported a net loss of CA$4.3M on revenue of CA$13.3M.

How much revenue does Adastra Holdings Ltd. make?

In fiscal 2022 Adastra Holdings Ltd. reported revenue of CA$13.3M. That is 136.2% more than a year earlier.

When did Adastra Holdings Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 17, 2023. It covers the period to December 31, 2022. Its newest filing of any kind is the deregistration from May 1, 2024.

Similar companies

Compare XTXXF with

Compare XTXXF with any company

Follow XTXXF

Get an email when Adastra Holdings Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow XTXXF

Free, no password. An email when XTXXF files with the SEC.

Where the numbers come from

Financial figures are the values Adastra Holdings Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.